This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
RLI Bolsters Shareholder Value, Increases Dividend by 4%
by Zacks Equity Research
RLI's recent 4% hike in dividend reflects its intention to enhance shareholders' value supported by its strong financial position.
Horace Mann (HMN) Q1 Earnings Lag Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of -31.91% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Eyes Q1 Earnings Beat on Cigna Healthcare Show
by Zacks Equity Research
Cigna's (CI) first-quarter 2022 results are likely to reflect improved pharmacy revenues in the Evernorth business.
Unum Group (UNM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Unum Group's (UNM) Q1 earnings are likely to have benefited from persistency, growth in the dental and vision product line and growth in the in-force block.
Prudential (PRU) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q1 results are likely to benefit from segmental strength and lower expense.
Is a Beat in the Cards for Assurant (AIZ) in Q1 Earnings?
by Zacks Equity Research
Assurant's (AIZ) first-quarter results are likely to reflect growth from strong U.S. sales in Global Automotive business, higher income from real estate-related investments, expansion in mobile within Connected Living and growth in Global Automotive.
Horace Mann (HMN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Horace Mann (HMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Horace Mann (HMN) Could Beat Earnings Estimates Again
by Zacks Equity Research
Horace Mann (HMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You Looking for a High-Growth Dividend Stock? Horace Mann (HMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
5 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help PRA, VOYA, HMN, AJG, and AFL outperform Q1 earnings estimates.
Why Should You Steer Clear of AMERISAFE (AMSF) Right Now?
by Zacks Equity Research
An escalating expense level and poor revenues make AMERISAFE (AMSF) an unattractive stock.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators are part of today's industry outlook article.
Why Horace Mann (HMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Why Should You Hold Aon's (AON) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on cost-cutting initiatives, strategic measures and a better bottom line, Aon (AON) holds potential to reap benefits for investors.
5 Multiline Insurers to Watch as Pandemic Impact Recedes
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, ORI and HMN as the impact of the pandemic recedes.
Why is Hold Strategy Appropriate for CNO Financial (CNO)?
by Zacks Equity Research
CNO Financial (CNO) has enough potential to reap benefits for investors owing to strong investments in technology and cost-cutting measures.
Here's Why You Should Hold on to Trupanion (TRUP) Stock Now
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given the change in the attitude of pet owners who are increasingly focusing on pets' health and well-being.
MetLife (MET) Unit Hits Milestone in Agricultural Mortgage Loans
by Zacks Equity Research
MetLife (MET) business unit MetLife Investment Management (MIM) creates a record by originating $6 billion in agricultural mortgage loans during 2021.
CME Group (CME) Unveils Micro-Sized Bitcoin and Ether Options
by Zacks Equity Research
CME Group (CME) introduces Micro Bitcoin and Micro Ether futures to add to the existing suite of cryptocurrency derivative offerings.
Should You Retain Prudential Financial (PRU) Stock Now?
by Zacks Equity Research
Prudential Financial (PRU) benefits from higher net investment spread and fee income, favorable underwriting results, and effective capital deployment.
Here's Why You Should Hold on to Argo Group (ARGO) Stock Now
by Zacks Equity Research
Argo Group's (ARGO) highly profitable businesses, exiting reinsurance operations and non-core lines of business, lowering property exposure substantially and reducing volatility bodes well for growth.
Here's Why You Should Hold on to Assurant (AIZ) Stock for Now
by Zacks Equity Research
Assurant (AIZ) is set to gain on solid segmental performance and sufficient liquidity.
Here's Why You Should Hold Hartford Financial (HIG) Stock
by Zacks Equity Research
Riding high on acquisitions and divestitures along with restructuring initiatives, Hartford Financial (HIG) has enough potential to reap benefits for investors.
Cigna Corp. (CI) Up 7.8% in 3 Months: More Room to Grow?
by Zacks Equity Research
Cigna Corp. (CI) expects to buy back more than $7 billion worth of shares in 2022.
Best Income Stocks to Buy for March 18th
by Zacks Equity Research
TTE, FISI, and HMN made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 18, 2022